Literature DB >> 15833682

Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.

Sunku H Guptha1, Anthony D Promnitz.   

Abstract

A 62-year-old Caucasian man with a history of Parkinson's disease developed bilateral pleural thickening and a large, right-sided, exudative pleural effusion. Further investigations revealed a chronic inflammatory process involving the pleura as a result of exposure to cabergoline used to treat the Parkinson's disease. The inflammatory process reversed after the discontinuation of cabergoline.

Entities:  

Year:  2005        PMID： 15833682     DOI： 10.1016/j.ejim.2004.09.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


  4 in total

1.  Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole.

Authors:  Dimitrios Parissis; Athanasia Papachristodoulou; Athanasios Dimitriadis
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 2.  Cabergoline in acromegaly.

Authors:  Emmanuelle Kuhn; Philippe Chanson
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Nicola Tarquinio; Lorenzo Nobili; Cinzia Nitti; Aldo Salvi; Gianluca Moroncini; Mauro Silvestrini
Journal:  Med Princ Pract       Date:  2021-07-07       Impact factor: 2.132

4.  Pleuropulmonary Toxicity of Another Anti-Parkinson's Drug: Cabergoline.

Authors:  Yolanda Belmonte; Oriol de Fàbregues; Marta Marti; Christian Domingo
Journal:  Open Respir Med J       Date:  2009-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.